Theravectys' Series B Round

Theravectys raised a round of funding on October 16, 2013.

Theravectys is a development-stage biotechnology company with a vaccine platform that can be applied to the treatment and prevention of a broad range of infectious diseases, cancers, and other disease…

Articles about Theravectys' Series B Round: